Bioorganic and Medicinal Chemistry Letters p. 1019 - 1022 (1998)
Update date:2022-08-05
Topics:
Sasaki, Shigeki
Hashimoto, Tomohiro
Obana, Norihiro
Yasuda, Hideyo
Uehara, Yoshimasa
Maeda, Minoru
New inhibitors have been designed for cdc2 kinase based on a multiple pseudosubstrate structure. The new inhibitors have three different structural components: 3,4-bis(indol-3-yl)maleimide, Ac-Cys-(Ser)-Pro-Lys-Lys-NHMe, and ethyloxy group between the two components. Inhibitory activities toward cdc2 and other protein kinases were investigated, and the compound (21) with Ac- Cys-Pro-Lys-Lys-NHMe connected with the triethylene glycol spacer exhibited the most potent inhibition with relatively high selectivity.
View MoreNanjing Xi Ze Biological Technology Co., Ltd
Contact:86-025-66023220
Address:Address: Nanjin Qixia District Maigaoqiao R & D base in Pioneer Park Chun Yin Road 18-A928
Synchem Pharma Co.,Ltd(expird)
Contact:+0086-21-61984905-1
Address:Building 60,Zimian Park, LongYang industrial Area, 1515Nong,Yuandong Road Fengxian District, Shanghai ,China
Shandong Jiulong Hisince Pharmaceutical Co.,Ltd.
Contact:+86-15853188990
Address:Huadian Pioneer Park, Huadian Township, Qihe County, Dezhou City, Shandong, P.R.China
Contact:--
Address:80G, No.1 Building, Guodu Development Mansion, No. 182 Zhaohui Road, Hangzhou City, Zhejiang Province,China.
zhuzhou zhongle chemical co. ltd.
Contact:+86-0731 28228409
Address:Zhuzhou, Hunan, China
Doi:10.1021/ic020375g
(2002)Doi:10.1016/S0277-5387(97)00376-8
(1998)Doi:10.1016/S0040-4039(00)72793-6
(1968)Doi:10.1016/S0040-4039(00)71266-4
(1991)Doi:10.1039/j39680002947
(1968)Doi:10.1016/S0957-4166(97)00128-6
(1997)